Advanced search
Publication Cover
Journal of Pain & Palliative Care Pharmacotherapy Volume 37, 2023 - Issue 2
Submit an article Journal homepage
263
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Gabapentin-Induced Overflow Urinary Incontinence: A Case Report and Review of the Literature

Sarah Masria Sarah Masri, PharmD, Don Scigliano, PharmD, and Katherine M. Juba, PharmD, are with the Department of Pharmacy Practice, St. John Fisher University, Rochester, NY, USA
, PharmD,
Anna E. Kenneyb Anna E. Kenney, DO and Katherine M. Juba, PharmD, are with the Division of Palliative Care, University of Rochester Medical Center, Rochester, NY, USA.ORCID Iconhttps://orcid.org/0000-0002-6464-0328
, DOORCID Icon,
Don Sciglianoa Sarah Masri, PharmD, Don Scigliano, PharmD, and Katherine M. Juba, PharmD, are with the Department of Pharmacy Practice, St. John Fisher University, Rochester, NY, USA
, PharmD &
Katherine M. Jubaa Sarah Masri, PharmD, Don Scigliano, PharmD, and Katherine M. Juba, PharmD, are with the Department of Pharmacy Practice, St. John Fisher University, Rochester, NY, USA;b Anna E. Kenney, DO and Katherine M. Juba, PharmD, are with the Division of Palliative Care, University of Rochester Medical Center, Rochester, NY, USA.Correspondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0240-2690
, PharmDORCID Icon
Pages 178-183 | Received 14 Sep 2022, Accepted 12 Dec 2022, Published online: 20 Dec 2022

References

  • Neurontin (gabapentin) prescribing information. New York, NY: Pfizer Inc; 2022 May. [accessed 2022 Oct. 13]. Available from: https://labeling.pfizer.com/ShowLabeling.aspx?id=630.
  • Fukada C, Kohler JC, Boon H, Austin Z, Krahn M. Prescribing gabapentin off label: perspectives from psychiatry, pain and neurology specialists. Can Pharm J (Ott). 2012;145(6):280–4.e1. doi:10.3821/145.6.cpj280.
  • Kibar S, Demir S, Sezer N, Köseoğlu BF, Dalyan Aras M, Kesikburun B. Gabapentin-induced urinary incontinence: a rare side effect in patients with neuropathic pain. Case Rep Neurol Med. 2015;2015:341573. doi:10.1155/2015/341573.
  • D'Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, Hamid R, Homma Y, Marcelissen T, Rademakers K, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019;38(2):433–77. doi:10.1002/nau.23897.
  • Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45. doi:10.1038/clpt.1981.154.
  • Handforth A, Treiman DM. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations. Epilepsia. 1994;35(5):1032–7. doi:10.1111/j.1528-1157.1994.tb02551.x.
  • Gil-Nagel A, Gapany S, Blesi K, Villanueva N, Bergen D. Incontinence during treatment with gabapentin. Neurology. 1997;48(5):1467–8. doi:10.1212/wnl.48.5.1467-a.
  • Iyer R, Egloff L, Fraas J, Harris J-D. Urinary and rectal incontinence during gabapentin therapy. J Support Oncol. 2008;6(4):152.
  • Kaler MS. Gabapentin induced urinary incontinence-a rare side effect. J Am Geriatr Soc. 2018;66(S2):S179.
  • Yepez Kuri JI, Andrade LC. Gabapentin-induced urine incontinence. J Am Geriatr Soc. 2018;66(S2):S30.
  • Rissardo JP, Caprara ALF. Gabapentin-associated urinary incontinence: a case verified by rechallenge. Clin Neuropharmacol. 2019;42(3):91–3. doi:10.1097/WNF.0000000000000334.
  • Mohammed M, Mullen L. A curious case of gabapentin-induced increased urinary frequency (5120). Neurology. 2021;96(15 Supplement):5120. https://n.neurology.org/highwire/citation/195355/download
  • U.S Food and Drug Administration. FDA Adverse Event Reporting System (FAERS) public dashboard [Internet]. FDA Adverse Event Reporting System (FAERS) Public Dashboard; 2021. [cited 2022 Oct 13]. Available from: https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard.
  • Hosseini SH, Makrani AH. Urinary incontinence following a single dose of pregabalin: A case report. J Mazandaran Univ Med Sci. 2016;25(132):338–42.
  • Toth C. Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy. Pain Med. 2010;11(3):456–65. doi:10.1111/j.1526-4637.2009.00796.x.
  • Cheng J-K, Chiou L-C. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci. 2006;100(5):471–86. doi:10.1254/jphs.cr0050020.
  • Lanneau C, Green A, Hirst WD, Wise A, Brown JT, Donnier E, J. Charles K, Wood M, Davies CH, Pangalos MN, et al. Gabapentin is not a GABAB receptor agonist. Neuropharmacology. 2001;41(8):965–75. doi:10.1016/S0028-3908(01)00140-X.
  • Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006;6(1):108–13. doi:10.1016/j.coph.2005.11.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.